Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Operating Expenses (2018 - 2025)

Historic Operating Expenses for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $61.3 million.

  • TransMedics' Operating Expenses rose 764.73% to $61.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.5 million, marking a year-over-year increase of 1884.12%. This contributed to the annual value of $224.6 million for FY2024, which is 2284.49% up from last year.
  • Per TransMedics' latest filing, its Operating Expenses stood at $61.3 million for Q3 2025, which was up 764.73% from $60.0 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Operating Expenses peaked at $69.0 million during Q3 2023, and registered a low of $11.3 million during Q1 2021.
  • Over the past 5 years, TransMedics' median Operating Expenses value was $37.6 million (recorded in 2023), while the average stood at $39.3 million.
  • In the last 5 years, TransMedics' Operating Expenses skyrocketed by 19163.11% in 2023 and then tumbled by 1750.08% in 2024.
  • TransMedics' Operating Expenses (Quarter) stood at $18.3 million in 2021, then soared by 50.06% to $27.5 million in 2022, then soared by 64.91% to $45.3 million in 2023, then skyrocketed by 39.82% to $63.4 million in 2024, then dropped by 3.3% to $61.3 million in 2025.
  • Its Operating Expenses was $61.3 million in Q3 2025, compared to $60.0 million in Q2 2025 and $60.8 million in Q1 2025.